|国家科技期刊平台
| 注册
首页|期刊导航|药物分析学报（英文）|Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC

Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC

Feifei Li Youyang Shi Mei Ma Xiaojuan Yang Xiaosong Chen Ying Xie Sheng Liu

药物分析学报（英文）2024，Vol.14Issue(10)：1450-1467,18.
✕
药物分析学报（英文）2024，Vol.14Issue(10)：1450-1467,18.DOI:10.1016/j.jpha.2024.100977

Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC

Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC

Feifei Li 1Youyang Shi 2Mei Ma 3Xiaojuan Yang 2Xiaosong Chen 4Ying Xie 5Sheng Liu1

作者信息

  • 1. Department of Breast Surgery,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai,200030,China||Institute of Chinese Traditional Surgery,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai,200030,China
  • 2. Department of Breast Surgery,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai,200030,China
  • 3. Institute of Toxicology,School of Public Health,Lanzhou University,Lanzhou,730000,China
  • 4. Department of General Surgery,Comprehensive Breast Health Center,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,200001,China
  • 5. Institute of Chinese Traditional Surgery,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai,200030,China
  • 折叠

摘要

关键词

HER2-positive breast cancer/Traditional chinese medicine/Trastuzumab/NK cell/ADCC effect

Key words

HER2-positive breast cancer/Traditional chinese medicine/Trastuzumab/NK cell/ADCC effect

引用本文复制引用

Feifei Li,Youyang Shi,Mei Ma,Xiaojuan Yang,Xiaosong Chen,Ying Xie,Sheng Liu..Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC[J].药物分析学报（英文）,2024,14(10):1450-1467,18.

基金项目

This work was supported by the National Natural Science Foundation of China(Grant No.:81774308),the Multi-center Clin-ical Research Project for Major Diseases of Shanghai Shenkang Hospital Development Center,China(Grant No.:SHDC2020CR1050B),and the High-level University Building Inno-vation Team,China(Grant No.:601521D). （Grant No.:81774308）

药物分析学报（英文）

2095-1779

访问量0
|
下载量0
段落导航相关论文